CHG

522

+2.15%↑

CHG

522

+2.15%↑

CHG

522

+2.15%↑

CHG

522

+2.15%↑

CHG

522

+2.15%↑

Search

Halma PLC

Deschisă

SectorSectorul industrial

3,884 0.47

Rezumat

Modificarea prețului

24h

Curent

Minim

3820

Maxim

3890

Indicatori cheie

By Trading Economics

Venit

107M

187M

Vânzări

651M

1.2B

P/E

Medie Sector

39.217

47.787

EPS

0.553

Randament dividend

0.67

Marjă de profit

15.096

Angajați

9,000

EBITDA

184M

317M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

-0.61% downside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.67%

2.01%

Statistici piață

By TradingEconomics

Capitalizare de piață

-166M

14B

Deschiderea anterioară

3883.53

Închiderea anterioară

3884

Sentimentul știrilor

By Acuity

34%

66%

95 / 406 Clasament în Industrials

Halma PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 feb. 2026, 23:21 UTC

Achiziții, Fuziuni, Preluări

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 feb. 2026, 23:45 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 feb. 2026, 23:40 UTC

Market Talk

Gold Falls on Possible Position Adjustments -- Market Talk

15 feb. 2026, 23:06 UTC

Câștiguri

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 feb. 2026, 23:04 UTC

Câștiguri

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 feb. 2026, 23:04 UTC

Câștiguri

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 feb. 2026, 23:01 UTC

Câștiguri

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 feb. 2026, 23:01 UTC

Câștiguri

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 feb. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 feb. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 feb. 2026, 22:52 UTC

Achiziții, Fuziuni, Preluări

Qube Shareholders to Receive A$5.20/Share in Cash

15 feb. 2026, 22:52 UTC

Achiziții, Fuziuni, Preluări

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 feb. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

BlueScope CEO Tania Archibald Speaking on a Call With Media

15 feb. 2026, 22:17 UTC

Achiziții, Fuziuni, Preluări

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15 feb. 2026, 22:16 UTC

Achiziții, Fuziuni, Preluări

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15 feb. 2026, 22:14 UTC

Achiziții, Fuziuni, Preluări

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15 feb. 2026, 22:14 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15 feb. 2026, 20:48 UTC

Câștiguri

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 feb. 2026, 20:47 UTC

Câștiguri

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 feb. 2026, 20:46 UTC

Câștiguri

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 feb. 2026, 20:45 UTC

Câștiguri

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 feb. 2026, 20:44 UTC

Câștiguri

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 feb. 2026, 20:44 UTC

Câștiguri

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 feb. 2026, 20:43 UTC

Câștiguri

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 feb. 2026, 20:42 UTC

Câștiguri

BlueScope Net Debt A$2.2 Million at Dec. 31

15 feb. 2026, 20:42 UTC

Câștiguri

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 feb. 2026, 20:41 UTC

Câștiguri

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 feb. 2026, 20:40 UTC

Câștiguri

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 feb. 2026, 20:40 UTC

Câștiguri

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 feb. 2026, 20:39 UTC

Câștiguri

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Comparație

Modificare preț

Halma PLC Așteptări

Obiectiv de preț

By TipRanks

-0.61% jos

Prognoză pe 12 luni

Medie 3,852.31 GBX  -0.61%

Maxim 4,280 GBX

Minim 2,490 GBX

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHalma PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

7

Cumpărare

5

Păstrare

1

Vânzare

Sentiment

By Acuity

95 / 406 Clasament în Sectorul industrial

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat